Sana Biotechnology (SANA) Other Non-Current Assets (2020 - 2026)

Sana Biotechnology's Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $563000.0 for Q1 2026.

• In Q1 2026, Other Non-Current Assets fell 86.6% year-over-year to $563000.0; the TTM figure through Mar 2026 stood at $563000.0 (down 86.6% YoY), while the FY2025 annual figure was $3.2 million, down 38.04% from the prior year.
• Other Non-Current Assets came in at $563000.0 for Q1 2026 at Sana Biotechnology, down from $3.2 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $10.5 million in Q2 2022 to a low of $563000.0 in Q1 2026.
• A 5-year average of $5.3 million and a median of $4.6 million in 2023 frame the typical range for Other Non-Current Assets.
• Across the five-year window, Other Non-Current Assets jumped 1266.46% in 2022 and tumbled 86.6% in 2026, its largest moves.
• Sana Biotechnology's Other Non-Current Assets stood at $4.6 million in 2022, then jumped by 38.51% to $6.4 million in 2023, then dropped by 19.61% to $5.1 million in 2024, then tumbled by 38.04% to $3.2 million in 2025, then sank by 82.26% to $563000.0 in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $563000.0, $3.2 million, and $4.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison